Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia - Editorial comment 1

被引：0
|
作者：
Thompson, IM [1 ]
Tangen, CM
机构：
[1] Univ Texas, Hlth Sci Ctr, Div Urol, San Antonio, TX 78284 USA
[2] Fred Hutchinson Canc Res Ctr, SW Oncol Grp, Ctr Stat, Seattle, WA 98104 USA
来源：
UROLOGY | 2004年 / 64卷 / 03期
关键词：
D O I：
10.1016/j.urology.2004.04.085
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [41] IMPACT OF PROSTATE-SPECIFIC ANTIGEN DENSITY IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE - EDITORIAL COMMENT
    OOSTERHOF, GON
    DEBRUYNE, F
    EUROPEAN UROLOGY, 1994, 25 (04) : 304 - 304
  • [42] Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia
    Lehrer, S
    Diamond, EJ
    Stone, NN
    Droller, MJ
    Stock, RG
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2431 - 2433
  • [43] Editorial Comment to Tamsulosin versus transurethral resection of the prostate: Effect on nocturia due to benign prostatic hyperplasia
    Milicevic, Snjezana
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (03) : 248 - 249
  • [44] Effect of daily 0.5mg oral dutasteride on prostate volume reduction in chinese men with symptomatic benign prostatic hyperplasia
    Yu, C.
    Chu, S. K.
    Man, C. W.
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A194 - A194
  • [45] The effect of tamsulosin and dutasteride combination drug therapy on prostate volume in patients with benign prostatic hyperplasia
    Nandana, P., I
    Adipura, L. R.
    Rasyid, H.
    3RD INTERNATIONAL CONFERENCE ON BIOSCIENCE AND BIOTECHNOLOGY, 2021, 712
  • [46] Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study
    Toren, Paul
    Margel, David
    Kulkarni, Girish
    Finelli, Antonio
    Zlotta, Alexandre
    Fleshner, Neil
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [47] Editorial Comment to Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men
    Kawahara, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (11) : 951 - 952
  • [48] Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 4 - 5
  • [49] Dutasteride/Tamsulosin (Jalyn) for Benign Prostatic Hyperplasia
    Wilson, Stephen A.
    Broders, Jennie
    AMERICAN FAMILY PHYSICIAN, 2012, 85 (12) : 1194 - 1195
  • [50] Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
    Antonino Catalano
    Gabriella Martino
    Federica Bellone
    Maria Papalia
    Carmen Lasco
    Giorgio Basile
    Alberto Sardella
    Giacomo Nicocia
    Nunziata Morabito
    Antonino Lasco
    Clinical Drug Investigation, 2019, 39 : 103 - 103
12345